Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 11 | 2025 | 1204 | 1.570 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2023 | 26 | 0.960 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2022 | 3 | 0.780 |
Why?
|
| Papilloma, Intraductal | 1 | 2022 | 6 | 0.780 |
Why?
|
| Carcinoma in Situ | 1 | 2022 | 35 | 0.750 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2020 | 20 | 0.680 |
Why?
|
| Adenoma | 1 | 2020 | 70 | 0.660 |
Why?
|
| Calcinosis | 1 | 2020 | 86 | 0.650 |
Why?
|
| Mammary Glands, Human | 2 | 2019 | 55 | 0.280 |
Why?
|
| Hyperplasia | 3 | 2023 | 89 | 0.280 |
Why?
|
| Breast | 3 | 2024 | 187 | 0.260 |
Why?
|
| Biopsy, Large-Core Needle | 2 | 2023 | 21 | 0.250 |
Why?
|
| Surgical Oncology | 1 | 2025 | 5 | 0.240 |
Why?
|
| Lymphoma, B-Cell | 1 | 2005 | 61 | 0.230 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2005 | 68 | 0.230 |
Why?
|
| Sentinel Lymph Node | 1 | 2025 | 13 | 0.230 |
Why?
|
| Nipples | 2 | 2023 | 14 | 0.220 |
Why?
|
| Personnel Selection | 1 | 2025 | 56 | 0.220 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2025 | 41 | 0.220 |
Why?
|
| Lymph Node Excision | 1 | 2025 | 46 | 0.220 |
Why?
|
| Mastectomy, Segmental | 1 | 2025 | 47 | 0.220 |
Why?
|
| Fellowships and Scholarships | 1 | 2025 | 107 | 0.220 |
Why?
|
| Precancerous Conditions | 1 | 2023 | 71 | 0.200 |
Why?
|
| Interviews as Topic | 1 | 2025 | 531 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2024 | 152 | 0.190 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2022 | 15 | 0.190 |
Why?
|
| Cicatrix | 1 | 2022 | 61 | 0.190 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2022 | 40 | 0.180 |
Why?
|
| Female | 12 | 2025 | 32945 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 337 | 0.180 |
Why?
|
| Retrospective Studies | 4 | 2025 | 6620 | 0.150 |
Why?
|
| Epithelial Cells | 2 | 2022 | 392 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 346 | 0.150 |
Why?
|
| Macrophages | 1 | 2024 | 1041 | 0.140 |
Why?
|
| Mammography | 1 | 2020 | 290 | 0.140 |
Why?
|
| Benzhydryl Compounds | 1 | 2018 | 51 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2025 | 1279 | 0.140 |
Why?
|
| Membrane Proteins | 2 | 2024 | 899 | 0.140 |
Why?
|
| Phenols | 1 | 2018 | 78 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2025 | 805 | 0.140 |
Why?
|
| Pandemics | 1 | 2022 | 671 | 0.130 |
Why?
|
| Humans | 13 | 2025 | 63533 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 85 | 0.130 |
Why?
|
| Transcriptome | 1 | 2019 | 386 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2017 | 381 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 616 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1617 | 0.090 |
Why?
|
| Middle Aged | 6 | 2025 | 17659 | 0.080 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2009 | 6 | 0.080 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2009 | 9 | 0.080 |
Why?
|
| Adult | 5 | 2025 | 16895 | 0.070 |
Why?
|
| Immunophenotyping | 1 | 2005 | 196 | 0.060 |
Why?
|
| Lymphedema | 1 | 2025 | 7 | 0.060 |
Why?
|
| Biopsy | 1 | 2005 | 447 | 0.050 |
Why?
|
| Radiography | 1 | 2005 | 551 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 81 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2023 | 89 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2023 | 88 | 0.050 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2022 | 13 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2025 | 349 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2023 | 340 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 843 | 0.040 |
Why?
|
| Mastectomy | 1 | 2018 | 58 | 0.040 |
Why?
|
| Mice | 2 | 2024 | 10863 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 230 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 158 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 147 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 13 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 2704 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2017 | 21 | 0.030 |
Why?
|
| Metabolomics | 1 | 2017 | 52 | 0.030 |
Why?
|
| Pregnancy | 1 | 2024 | 2335 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 456 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 326 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 295 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 507 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 769 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 14457 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 5468 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1170 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2113 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1406 | 0.030 |
Why?
|
| Animals | 2 | 2024 | 20715 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 1208 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2196 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 3710 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 3033 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 167 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2009 | 311 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4713 | 0.020 |
Why?
|
| Male | 1 | 2025 | 29937 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 778 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 1185 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2009 | 1515 | 0.010 |
Why?
|